POLYMORPHISMS OF ENDOTHELIAL NITRIC OXIDE SYNTHASE GENE AS PREDICTORS OF WOLFF-PARKINSON-WHITE SYNDROME
https://doi.org/10.20996/1819-6446-2017-13-5-597-601
Abstract
Background. The discovery of new genetic predictors of cardiovascular diseases can be used in predicting and diagnosing latent forms of the disease. Wolff-Parkinson-White syndrome (WPW) occurs in all age groups and detected in 1-30 people per 10000, it manifests mainly in young age (on average 20 years), and the risk of sudden cardiac death is higher than in general population.
Aim. To study the relationship of WPW syndrome with the polymorphism of endothelial nitric synthase gene (NOS3), and to identify genetic predictors of this syndrome.
Material and methods. The study included 51 people with ECG proven WPW syndrome and 153 people with no cardiovascular disease. The patients were divided into subgroups according to sex: 21 women, 30 men. All patients underwent a standard cardiac examination (anamnesis, electrocardiography, echocardiography, bicycle ergometry, transesophageal electrical stimulation of the atria, Holter monitoring) and blood was taken for molecular genetic testing of DNA.
Results. The results showed a statistically significant prevalence of rare genotype 4b\4b NOS3 gene in the control group of women (16.3%; р<0.05) compared with women from the main group, who did not have this genotype, while there was significant prevalence of genotype 4a\4a in the main group of women (81.0%; р<0.05) compared with women from the control group. In men this prevalence was not found.
Conclusion. The presence of genotype 4b\4b NOS3 gene reduces the likelihood of WPW syndrome and its symptoms in females. In men, this prevalence is not found, presumably, in connection with some mechanisms of hormonal regulation. The results can be used in the genetic prediction of the course of the disease.
About the Authors
G. V. MatyushinRussian Federation
Gennady V. Matyushin – MD, PhD, Professor, Head of Department of Cardiology and Functional Diagnostics, Institute of Postgraduate Education.
Partizana Zheleznyaka ul. 1, Krasnoyarsk, 660022
S. Yu. Nikulina
Russian Federation
Svetlana Yu. Nikulina – MD, PhD, Professor, Head of Chair of Internal Diseases №1.
Partizana Zheleznyaka ul. 1, Krasnoyarsk, 660022
A. A. Chernova
Russian Federation
Anna A. Chernova – MD, PhD, Associate Professor, Chair of Internal Diseases №1.
Partizana Zheleznyaka ul. 1, Krasnoyarsk, 660022
I. I. Lebedeva
Russian Federation
Ilona I. Lebedeva – MD, Post-Graduate Student, Chair of Internal Diseases №1.
Partizana Zheleznyaka ul. 1, Krasnoyarsk, 660022
A. A. Semenchukov
Russian Federation
Aleksej A. Semenchukov – Researcher, Russian-Italian Laboratory of Medical Genetics.
Partizana Zheleznyaka ul. 1, Krasnoyarsk, 660022
References
1. Bokerija L.A., Melikulov A.H. Wolff-Parkinson-White syndrome. Annaly Aritmologii. 2008;2:5-19. (In Russ.) [БокерияЛ.А., МеликуловА.Х. Синдром Вольфа-Паркинсона-Уайта. Анналы Аритмологии. 2008;2:5-19].
2. Ardashev A.V., Rybachenko M.S., Zheljakov E. G., et al. Wolff-Parkinson-White syndrome: classification, clinical manifestations, diagnosis and treatment. Kardiologiia. 2009;10:84-94. (In Russ.) [Ардашев А.В., Рыбаченко М.С., Желяков Е.Г. и др. Синдром Вольфа—Паркинсона—Уайта: классификация, клинические проявления, диагностика и лечение. Кардиология. 2009;10:84-94].
3. Vatutin N.T., Kalinkina N.V. Syndrome of ventricles preexcitation. Syndromes in cardiology. Donetsk: Kashtan; 2010. (In Russ.) [Ватутин Н.Т., Калинкина Н.В. Синдром преждевременного возбуждения желудочков. Синдромы в кардиологии. Донецк: Каштан; 2010].
4. Lu C-W., Wua M-H., Chen H-C., et al. Epidemiological profile of Wolff-Parkinson-White syndrome in a general population younger than 50 years of age in an era of radiofrequency catheter ablation. International Journal of Cardiology. 2014;4:530-4.
5. Vaughan CJ., Hom Y., Okin D.A., et al. Molecular genetic analysis of PRKAG2 in sporadic WolffParkinson-White syndrome. J Cardiovasc Electrophysiol. 2003;14:263-8.
6. Battelino N., Sebestjen M., Keber I., et al. Endothelial nitric oxide synthase T(-786)C polymorphism in children and adolescents with type 1 diabetes and impaired endothelium-dependent dilatation. Horm Res Paediatr. 2011;4:248-53.
7. Alvarez R., Gonzalez P., Batalla A., et al. Association between the NOS3 (-786 T/C) and the ACE (I/D) DNA genotypes and early coronary artery disease. Nitric Oxide. 2001;5:343-8.
8. Tepljakov A.T., Shilov S.N., Berezikova E.N., et al. Polymorphism of eNOS and iNOS genes in chronic heart failure in patients with ischemic heart disease. Kardiologiia. 2010;4:23-30. (In Russ.) [Тепляков А.Т., Шилов С.Н., Березикова Е.Н., и др. Полиморфизм генов еNOS и iNOS при хронической сердечной недостаточности у больных ишемической болезнью сердца. Кардиология. 2010;4:23-30].
9. Chernova A.A., Nikulina S.Ju., Maksimov V.N. et al. Polymorphic variants of the eNOS gene in patients with impaired cardiac conduction. Kardiologiia. 2014;10:26-31. (In Russ.) [Чернова А.А., Никулина С.Ю., Максимов В.Н., и др. Полиморфные варианты гена eNOS у больных с нарушением сердечной проводимости. Кардиология. 2014;10:26-31].
10. Jaffe M.D. Effect of testosterone cypionate on postexercise ST segment depression. Br Heart J. 1977;39(11):1217-22.
11. Semyachkina-Glushkovskaya О., Pavlov А., Semyachkin-Glushkovskiy I., et al. Role of testosterone in resistance to development of stress-related vascular diseases in male and female organisms: models of hypertension and ulcer bleeding. Proc of SPIE. 2015;9448:9448IH.
Review
For citations:
Matyushin G.V., Nikulina S.Yu., Chernova A.A., Lebedeva I.I., Semenchukov A.A. POLYMORPHISMS OF ENDOTHELIAL NITRIC OXIDE SYNTHASE GENE AS PREDICTORS OF WOLFF-PARKINSON-WHITE SYNDROME. Rational Pharmacotherapy in Cardiology. 2017;13(5):597-601. (In Russ.) https://doi.org/10.20996/1819-6446-2017-13-5-597-601